Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Advanced provider by MediFind in the treatment of Transient Erythroblastopenia of Childhood. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy.

Dr. DeZern is a Professor of Oncology and Medicine at The Johns Hopkins University School of Medicine. She is active in the Division of Hematology Malignancies, Leukemia Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. DeZern has expertise in aplastic anemia, myelodysplastic syndromes, paroxysmal nocturnal hemoglobinuria, acute myeloid leukemia, and bone marrow transplantation. Dr. DeZern received her medical degree at The Johns Hopkins University School of Medicine. She completed a residency in internal medicine at Johns Hopkins, followed by fellowships in medical oncology and hematology, as well as obtained a Masters in Clinical Investigations at the Bloomberg School of Public health. Dr. DeZern is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the American Society for Transplantation and Cellular Therapy. Dr. DeZern’s principle research activities consist of designing and conducting clinical trials that test investigational new therapies and approaches in the treatment of bone marrow failure (aplastic anemia and myelodysplastic syndromes). She has specific expertise in the use of alternative donor bone marrow transplantation in patients with severe aplastic anemia and trials of novel therapeutics for patients with myelodysplastic syndromes. Additionally, she has taken a rigorous approach to the study of diagnostics and supportive case (such as transfusion practices) in these patient populations. She is or has been the Principal Investigator for a number of multicenter trials in collaboration with the MDS Clinical Research Consortium, the Eastern Co-operative Oncology Group (ECOG)-ACRIN and now the Bone Marrow Trials Clinical Trials Network (BMTCTN). She is the Study Chair for the multi-site BMTCTN study (CHAMP) investigating the role of haploidentical donor transplantation using post-transplantation cyclophosphamide in patients with relapsed several aplastic anemia. Dr. DeZern is the local PI as well as the Deputy Chair for The National MDS Study, a collaborative natural history study of the NHLBI and the NCI. As a clinical investigator with a focus on translation of novel treatments to the clinic, Dr. DeZern’s goal is to improve outcomes for patients with bone marrow failure at the bedside and in her research environment. Dr. Dezern is rated as an Experienced provider by MediFind in the treatment of Transient Erythroblastopenia of Childhood. Her top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with. Dr. Naik is rated as an Experienced provider by MediFind in the treatment of Transient Erythroblastopenia of Childhood. Her top areas of expertise are Sickle Cell Disease, Hemolytic Anemia, Hemoglobinopathy, and Congenital Hemolytic Anemia.

Beth Carella is a Pediatric Hematologist Oncology provider in Baltimore, Maryland. Dr. Carella is rated as an Experienced provider by MediFind in the treatment of Transient Erythroblastopenia of Childhood. Her top areas of expertise are Sickle Cell Disease, Transient Erythroblastopenia of Childhood, Aase Syndrome, and Hemoglobin SC Disease.

Natalie Davis is a Neonatologist and a Pediatrics provider in Baltimore, Maryland. Dr. Davis is rated as an Experienced provider by MediFind in the treatment of Transient Erythroblastopenia of Childhood. Her top areas of expertise are Infantile Apnea, Premature Infant, Necrotizing Enterocolitis, and Microcephaly. Dr. Davis is currently accepting new patients.

Regina Macatangay is a Pediatric Hematologist Oncology provider in Baltimore, Maryland. Dr. Macatangay is rated as an Experienced provider by MediFind in the treatment of Transient Erythroblastopenia of Childhood. Her top areas of expertise are Hemoglobin SC Disease, Sickle Cell Disease, Acute Lymphoblastic Leukemia (ALL), and Anemia.

Nancy Braverman is a Medical Genetics specialist and a Pediatrics provider in Baltimore, Maryland. Dr. Braverman is rated as an Experienced provider by MediFind in the treatment of Transient Erythroblastopenia of Childhood. Her top areas of expertise are Zellweger Syndrome, Chondrodysplasia Punctata Syndrome, X-Linked Chondrodysplasia Punctata 2, and Acromesomelic Dysplasia.

Gregory Prokopowicz is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Prokopowicz is rated as an Experienced provider by MediFind in the treatment of Transient Erythroblastopenia of Childhood. His top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Sleeve Gastrectomy, and Gastric Bypass.

Jerry Spivak is a Hematologist in Baltimore, Maryland. Dr. Spivak is rated as an Experienced provider by MediFind in the treatment of Transient Erythroblastopenia of Childhood. His top areas of expertise are Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, and Myeloproliferative Neoplasms (MPN).

Syed Nasir is a Hematologist and an Oncologist in Towson, Maryland. Dr. Nasir is rated as an Experienced provider by MediFind in the treatment of Transient Erythroblastopenia of Childhood. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Paget Disease of the Breast.

Ramana Gopalan is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Gopalan is rated as an Experienced provider by MediFind in the treatment of Transient Erythroblastopenia of Childhood. His top areas of expertise are Dementia, Anorectal Abscess, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension.

Kevin Chen is a Hematologist and an Oncologist in Baltimore, Maryland. Dr. Chen has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Transient Erythroblastopenia of Childhood. His top areas of expertise are Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC).